Topical Diindolylmethane Formulation for Skin Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for skin conditions such as acne, atopic dermatitis, rosacea, and skin aging are inadequate in providing effective and targeted therapeutic solutions.
Innovation Solution
A topical composition comprising emulsified substituted or unsubstituted diindolylmethane (DIM) is administered to provide a therapeutically effective amount of DIM to the skin, thereby treating skin conditions and skin aging.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for skin conditions are used, then skin conditions such as acne, atopic dermatitis, rosacea, and skin aging are treated, but the treatments are inadequate in providing effective and targeted therapeutic solutions
Solution Approach 1:
The patent applies local quality by formulating DIM in specific topical dosage forms (creams, gels, lotions, serums) with optimized concentrations (0.1-10 wt%) tailored for specific skin conditions. Each formulation is designed with specific excipients and delivery systems to target particular skin layers and conditions, providing localized effective treatment rather than generic systemic approaches.
Solution Approach 2:
The patent employs parameter changes by optimizing the concentration of DIM in topical formulations (0.1-10 wt%), adjusting pH levels, selecting specific excipients, and controlling particle size for emulsified DIM. These parameter optimizations enhance the stability, penetration, and bioavailability of DIM, transforming it into an effective topical therapeutic agent for various skin conditions.
2Quantity of substance
If DIM is administered topically to treat skin conditions, then dermal bioavailability is significantly increased, but the complexity of achieving therapeutically effective amounts in skin is increased
Solution Approach 1:
The patent uses excipients and delivery systems as intermediaries to facilitate DIM penetration into the skin. These include emulsifiers, penetration enhancers, and base formulations that act as mediators between the DIM molecule and the skin barrier, enabling effective delivery without requiring complex delivery devices or invasive procedures.
Solution Approach 2:
The patent creates composite topical formulations by combining DIM with pharmaceutically acceptable excipients, emulsifiers, and delivery vehicles. These composite materials (creams, gels, lotions, serums) integrate multiple functional components that work synergistically to enhance DIM stability, solubility, and skin penetration while maintaining ease of application.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The topical administration of DIM significantly increases dermal bioavailability, leading to enhanced pharmacokinetic parameters such as Cmax and AUC, and provides effective treatment for acne, atopic dermatitis, rosacea, and skin aging.
Implementation Method 1
administering to the subject a topical composition comprising a substituted or unsubstituted diindolylmethane... the composition provides therapeutically effective amount of the substituted or unsubstituted diindolylmethane in the subject's skin
Data Source
AI summary
Described herein are methods for treating one or more skin conditions by administering, via the topical route, a composition comprising substituted or unsubstituted diindolylmethane. In particular, methods are provided for improving the dermal bioavailability and pharmacokinetic parameters of substituted or unsubstituted diindolylmethane following a topical administration, relative to an oral administration or a sublingual or buccal administration.